基于SUV的PET对 4周期化疗后的弥漫大B细胞淋巴瘤患者预后的评估
评价者:宋玉琴
1
, 文献合成者:黄玲
2
The Prognostic Significance of SUV-Based Assessment of Interim PET in Diffuse Large B-Cell Lymphoma Patients with 4 Cycles of Chemotherapy
Reviewer:SONG Yu-qin
1
, Literature Co-worker: HUANG Ling
2
图1 研究流程图